# The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)

> **NCT02400190** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 202 (actual)

## Conditions studied

- Breast Neoplasms

## Interventions

- **OTHER:** endocrine therapy alone without radiotherapy

## Key facts

- **NCT ID:** NCT02400190
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2015-05-27
- **Primary completion:** 2026-05
- **Final completion:** 2026-05
- **Target enrollment:** 202 (ACTUAL)
- **Last updated:** 2025-10-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02400190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02400190, "The IDEA Study (Individualized Decisions for Endocrine Therapy Alone)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02400190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*